Efficacy Of Virechana alongwith oral administration of Kanashatahwadi Kashaya and Sthaulyahara Ghana Vati in the management of Obese Polycystic Ovarian Syndrome – An Open Label Prospective Single Arm Clinical Trial - NI

Institute of Teaching and Research in Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年11月13日

研究概览

暂无简介。

•1)20 to 40 years of age
•2)Both married and unmarried patients
•3)Patients with BMI 30.0 to 34.9 (Obesity class I) & 35.0 to 39.9 (Obesity class II) as per WHO’s Classification of Obesity
•4)Diagnosed cases as per Rotterdam Diagnostic criteria of PCOS.
•5)Patient who provide voluntary agreement for participation in the trial and provide informed consent prior to treatment.

•1) Young females who had their menarche in less than 3 years
•2) Lactating mothers
•3) Patient not willing to participate in this study
•4) Patients who are unfit for the interventional procedure like Snehana, Swedana, and Virechana Karma
•5) Patients having Endocrinopathies.
•6) Known case of Premature ovarian failure
•7) Patients having Organic lesions of reproductive tract
•8) Patients having systemic disorders like severe cardiac, pulmonary, hepatic, or renal diseases, central nervous system disorder, Hypertension (Systolic BP greater than or equal to 160 and Diastolic greater than or equal to 100mmhg)
•9) Patients with medications currently taking or took within 3 months like high dose exogenous androgens, hormonal treatment for PCOS, a current or previous use of OC pills, glucocorticoids, anti- androgens, ovulation induction agents, anti-diabetic, anti-obesity drug or other hormonal drugs

发起方

Institute of Teaching and Research in Ayurveda